FSH (Follicle-Stimulating Hormone)
| Clinical | Optimal | |
|---|---|---|
| Male | 1.5 - 12.4 IU/L | 1.5–12.4 IU/L |
| Female | Follicular: 3.5-12.5 IU/L; Ovulation: 4.7-21.5 IU/L; Luteal: 1.7-7.7 IU/L; Postmenopausal: 25.8-134.8 IU/L | Follicular phase: 3.5–12.5 IU/L, Ovulation: 4.7–21.5 IU/L, Luteal: 1.7–7.7 IU/L, Postmenopausal: 25.8–134.8 IU/L |
What is FSH (Follicle-Stimulating Hormone)?
Follicle-stimulating hormone (FSH) is produced by the pituitary gland — a pea-sized gland at the base of your brain that acts as the master controller of many hormone systems. FSH stimulates the growth and maturation of eggs in the ovaries (in women) and sperm production in the testes (in men).
In women, FSH levels fluctuate throughout the menstrual cycle. It is highest at the start of the cycle (days 2–5) when it stimulates follicle development, and drops once a dominant follicle is selected. FSH measured on days 2–5 provides the most clinically useful information about ovarian reserve.
In men, FSH levels are relatively stable and reflect the health of sperm-producing cells in the testes. The pituitary gland continuously monitors testosterone and other testicular signals, adjusting FSH output accordingly.
Why FSH (Follicle-Stimulating Hormone) Matters for Your Health
FSH is one of the most important markers for assessing reproductive function and hormonal status. In women, early follicular phase FSH provides insight into ovarian reserve — the remaining egg supply. As ovarian reserve diminishes with age, FSH rises because the pituitary works harder to stimulate the ovaries.
For women considering fertility preservation or family planning, FSH alongside AMH (anti-Mullerian hormone) provides the most comprehensive assessment of ovarian reserve. Elevated FSH may indicate approaching menopause or reduced fertility.
In men, FSH helps distinguish between different causes of low testosterone or infertility. High FSH suggests the testes themselves are underperforming (primary hypogonadism), while low FSH suggests the pituitary is not sending adequate signals (secondary hypogonadism).
FSH (Follicle-Stimulating Hormone)& Your Wearable Data
Follicle-stimulating hormone (FSH) is produced by the pituitary gland and plays a central role in reproductive function: stimulating egg development in women and sperm production in men. In women, FSH varies across the menstrual cycle, with wearable cycle tracking helping determine the appropriate phase for testing. Elevated FSH is a marker of diminishing ovarian reserve or approaching menopause.
While wearables do not directly measure FSH, they can detect its downstream effects. In perimenopause, rising FSH causes cycle irregularity, hot flushes (detectable through wearable temperature sensors), sleep disruption (tracked by sleep monitoring), and altered heart rate patterns. These wearable-detected changes often precede significant FSH elevation in blood tests.
Exercise intensity influences the hypothalamic-pituitary-gonadal axis that controls FSH. Extreme exercise without adequate energy intake, visible in wearable data as very high training volumes with low calorie expenditure ratio, can suppress FSH through hypothalamic amenorrhoea. Wearable data showing this pattern alongside missed periods warrants hormonal investigation.
What High FSH (Follicle-Stimulating Hormone) May Suggest
In women, high FSH (particularly on days 2–5 of the cycle) suggests reduced ovarian reserve — the ovaries are responding less to stimulation, so the pituitary produces more FSH to compensate. This is a natural part of ageing and becomes more pronounced in the years approaching menopause. In premenopausal women under 40, significantly elevated FSH may indicate premature ovarian insufficiency.
In postmenopausal women, high FSH is entirely expected and normal — it confirms that the ovaries have ceased regular function.
In men, high FSH suggests the testes are underperforming in sperm production (primary testicular failure). This can result from previous infections (mumps orchitis), chemotherapy, radiation, genetic conditions (Klinefelter syndrome), varicocele, or idiopathic causes. High FSH in men warrants a semen analysis and possibly a urology referral.
What Low FSH (Follicle-Stimulating Hormone) May Suggest
In women, low FSH in the early follicular phase is generally reassuring and suggests adequate ovarian reserve. However, very low FSH across the cycle can indicate pituitary insufficiency (hypopituitarism), where the pituitary is not producing enough hormones. This can result from pituitary tumours, head injury, severe stress, extreme exercise, or very low body weight.
In men, low FSH suggests the pituitary is not adequately stimulating the testes. This can be caused by pituitary disease, exogenous testosterone use (which strongly suppresses pituitary FSH and LH), opioid medications, extreme obesity, or significant chronic illness.
Low FSH in men taking testosterone is expected — it is the mechanism by which TRT suppresses natural sperm production and can lead to infertility.
How to Optimise Your FSH (Follicle-Stimulating Hormone)
Food
Support overall hormonal health with a nutrient-dense diet: adequate healthy fats (essential for hormone production), zinc-rich foods (oysters, pumpkin seeds), antioxidant-rich fruits and vegetables, and sufficient protein. Avoid extreme caloric restriction, which suppresses pituitary function. For women trying to support ovarian health: include CoQ10-rich foods (sardines, organ meats, broccoli) and antioxidant-rich berries.
Lifestyle
Maintain a healthy body weight — both extremes (underweight and significantly overweight) disrupt pituitary-gonadal signalling. Manage chronic stress, as cortisol can suppress pituitary function. Ensure quality sleep. Avoid excessive endurance exercise, which can suppress reproductive hormones in both sexes. Limit alcohol and avoid smoking. For women concerned about ovarian reserve, discussing timeline planning with a fertility specialist can be valuable.
Supplements
CoQ10 (200–600 mg daily) may support ovarian function and egg quality in women. DHEA (under medical supervision only) is sometimes used to support ovarian response in women with diminished reserve. Vitamin D (1,000–2,000 IU daily) supports pituitary-gonadal axis function. Myo-inositol (2–4g daily) may support ovarian function in women with hormonal imbalances.
When to Speak to Your GP
Women: see your GP if FSH is elevated on day 2–5 testing (above 12 IU/L in premenopausal women), particularly if you are trying to conceive or are under 40. Also consult if periods have stopped for more than 3 months. Men: see your GP if FSH is elevated (above 12 IU/L) alongside low testosterone, as this may indicate primary testicular failure. Low FSH with low testosterone suggests pituitary investigation is needed.
References
- NHS. Menopause — Diagnosis. Updated 2024. nhs.uk
- NICE. Menopause: diagnosis and management. NG23. nice.org.uk
- NICE. Fertility problems: assessment and treatment. CG156. nice.org.uk
- BMJ. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril. 2008;90(5 Suppl):S219-225. pubmed.ncbi.nlm.nih.gov
Medical Disclaimer— This content is for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Omniwo Ltd is a wellness information service and is not a medical device, clinical laboratory, or regulated healthcare provider under MHRA guidelines. The “optimal ranges” presented on this page are based on published clinical guidelines (WHO, NICE, NHS) and peer-reviewed research; they represent functional wellness targets and may differ from standard laboratory reference ranges. Individual results should always be interpreted by a qualified healthcare professional (such as your GP) who understands your full medical history. Do not start, stop, or change any medication or supplement based solely on this information. If you are experiencing symptoms, seek medical attention promptly.